Herrlinger U - Search Results

1

Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option.

Flieger M, Ganswindt U, Schwarz SB, Kreth FW, Tonn JC, la Fougère C, Ertl L, Linn J, Herrlinger U, Belka C, Niyazi M. Flieger M, et al. Among authors: herrlinger u. J Neurooncol. 2014 Apr;117(2):337-45. doi: 10.1007/s11060-014-1394-5. Epub 2014 Feb 7. J Neurooncol. 2014. PMID: 24504501

2

Intrathecal treatment of C6 glioma leptomeningeal metastasis in Wistar rats with interleukin-2.

Herrlinger U, Buchholz R, Jachimczak P, Schabet M. Herrlinger U, et al. J Neurooncol. 1996 Mar;27(3):193-203. doi: 10.1007/BF00165475. J Neurooncol. 1996. PMID: 8847552

3

Treosulfan chemotherapy for recurrent malignant glioma.

Schmidt F, Wick W, Herrlinger U, Dichgans J, Weller M. Schmidt F, et al. Among authors: herrlinger u. J Neurooncol. 2000 Sep;49(3):231-4. doi: 10.1023/a:1006496831144. J Neurooncol. 2000. PMID: 11212902 Clinical Trial.

4

MIP-1alpha antagonizes the effect of a GM-CSF-enhanced subcutaneous vaccine in a mouse glioma model.

Herrlinger U, Aulwurm S, Strik H, Weit S, Naumann U, Weller M. Herrlinger U, et al. J Neurooncol. 2004 Jan;66(1-2):147-54. doi: 10.1023/b:neon.0000013497.04322.fc. J Neurooncol. 2004. PMID: 15015780

5

UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastoma.

Herrlinger U, Rieger J, Steinbach JP, Nägele T, Dichgans J, Weller M. Herrlinger U, et al. J Neurooncol. 2005 Feb;71(3):295-9. doi: 10.1007/s11060-004-1726-y. J Neurooncol. 2005. PMID: 15735920 Clinical Trial.

6

Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors.

Jahnke K, Thiel E, Martus P, Herrlinger U, Weller M, Fischer L, Korfel A; German Primary Central Nervous System Lymphoma Study Group. Jahnke K, et al. Among authors: herrlinger u. J Neurooncol. 2006 Nov;80(2):159-65. doi: 10.1007/s11060-006-9165-6. Epub 2006 May 13. J Neurooncol. 2006. PMID: 16699873

7

Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma.

Wick A, Felsberg J, Steinbach JP, Herrlinger U, Platten M, Blaschke B, Meyermann R, Reifenberger G, Weller M, Wick W. Wick A, et al. Among authors: herrlinger u. J Clin Oncol. 2007 Aug 1;25(22):3357-61. doi: 10.1200/JCO.2007.10.7722. J Clin Oncol. 2007. PMID: 17664483 Clinical Trial.

8

Pegylated liposomal doxorubicin in recurrent malignant glioma: analysis of a case series.

Glas M, Koch H, Hirschmann B, Jauch T, Steinbrecher A, Herrlinger U, Bogdahn U, Hau P. Glas M, et al. Among authors: herrlinger u. Oncology. 2007;72(5-6):302-7. doi: 10.1159/000113052. Epub 2008 Jan 14. Oncology. 2007. PMID: 18198491

9

Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastoma.

Glas M, Hundsberger T, Stuplich M, Wiewrodt D, Kurzwelly D, Nguyen-Huu B, Rasch K, Herrlinger U. Glas M, et al. Among authors: herrlinger u. Oncology. 2009;76(3):184-9. doi: 10.1159/000201943. Epub 2009 Feb 13. Oncology. 2009. PMID: 19218824

10

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.

Thiel E, Korfel A, Martus P, Kanz L, Griesinger F, Rauch M, Röth A, Hertenstein B, von Toll T, Hundsberger T, Mergenthaler HG, Leithäuser M, Birnbaum T, Fischer L, Jahnke K, Herrlinger U, Plasswilm L, Nägele T, Pietsch T, Bamberg M, Weller M. Thiel E, et al. Among authors: herrlinger u. Lancet Oncol. 2010 Nov;11(11):1036-47. doi: 10.1016/S1470-2045(10)70229-1. Epub 2010 Oct 20. Lancet Oncol. 2010. PMID: 20970380 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters